Jennison Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-332,018
| Closed | -$32M | – | 582 |
|
|
2023
Q4 | $32M | Sell |
332,018
-257,326
| -44% | -$24.8M | 0.02% | 265 |
|
|
2023
Q3 | $52.1M | Buy |
589,344
+411,543
| +231% | +$36.4M | 0.04% | 169 |
|
|
2023
Q2 | $15.4M | Sell |
177,801
-496,307
| -74% | -$43M | 0.01% | 346 |
|
|
2023
Q1 | $65.6M | Buy |
674,108
+95,485
| +17% | +$9.28M | 0.06% | 152 |
|
|
2022
Q4 | $59.9M | Buy |
578,623
+15,117
| +3% | +$1.56M | 0.06% | 160 |
|
|
2022
Q3 | $47.8M | Sell |
563,506
-165,664
| -23% | -$14M | 0.05% | 179 |
|
|
2022
Q2 | $60.4M | Buy |
729,170
+22,642
| +3% | +$1.88M | 0.06% | 156 |
|
|
2022
Q1 | $54.5M | Buy |
706,528
+153,984
| +28% | +$11.9M | 0.04% | 189 |
|
|
2021
Q4 | $48.8M | Buy |
+552,544
| New | +$48.8M | 0.03% | 225 |
|
|
2021
Q1 | – | Sell |
-453,994
| Closed | -$39.8M | – | 666 |
|
|
2020
Q4 | $39.8M | Sell |
453,994
-198,798
| -30% | -$17.4M | 0.03% | 246 |
|
|
2020
Q3 | $49.7M | Sell |
652,792
-6,937,973
| -91% | -$528M | 0.04% | 182 |
|
|
2020
Q2 | $936M | Sell |
7,590,765
-623,698
| -8% | -$76.9M | 0.85% | 36 |
|
|
2020
Q1 | $694M | Buy |
8,214,463
+1,174,290
| +17% | +$99.2M | 0.84% | 31 |
|
|
2019
Q4 | $595M | Sell |
7,040,173
-1,291,227
| -15% | -$109M | 0.6% | 43 |
|
|
2019
Q3 | $562M | Sell |
8,331,400
-1,116,415
| -12% | -$75.2M | 0.59% | 43 |
|
|
2019
Q2 | $809M | Sell |
9,447,815
-2,964,778
| -24% | -$254M | 0.8% | 39 |
|
|
2019
Q1 | $1.1B | Buy |
12,412,593
+812,133
| +7% | +$72.1M | 1.09% | 29 |
|
|
2018
Q4 | $988M | Buy |
11,600,460
+756,222
| +7% | +$64.4M | 1.11% | 26 |
|
|
2018
Q3 | $1.05B | Sell |
10,844,238
-744,393
| -6% | -$72.2M | 0.97% | 32 |
|
|
2018
Q2 | $1.09B | Sell |
11,588,631
-174,192
| -1% | -$16.4M | 1.06% | 28 |
|
|
2018
Q1 | $954M | Sell |
11,762,823
-46,872
| -0.4% | -$3.8M | 0.95% | 34 |
|
|
2017
Q4 | $1.05B | Sell |
11,809,695
-504,662
| -4% | -$45M | 1.04% | 31 |
|
|
2017
Q3 | $1.15B | Sell |
12,314,357
-928,416
| -7% | -$86.4M | 1.17% | 23 |
|
|
2017
Q2 | $1.2B | Buy |
13,242,773
+3,348,168
| +34% | +$304M | 1.28% | 24 |
|
|
2017
Q1 | $869M | Buy |
9,894,605
+631,147
| +7% | +$55.4M | 0.93% | 30 |
|
|
2016
Q4 | $767M | Sell |
9,263,458
-438,742
| -5% | -$36.3M | 0.86% | 31 |
|
|
2016
Q3 | $898M | Buy |
9,702,200
+650,956
| +7% | +$60.2M | 0.97% | 27 |
|
|
2016
Q2 | $704M | Buy |
9,051,244
+301,353
| +3% | +$23.4M | 0.77% | 36 |
|
|
2016
Q1 | $722M | Buy |
8,749,891
+2,058,540
| +31% | +$170M | 0.76% | 41 |
|
|
2015
Q4 | $701M | Buy |
6,691,351
+1,739,328
| +35% | +$182M | 0.69% | 43 |
|
|
2015
Q3 | $522M | Sell |
4,952,023
-546,799
| -10% | -$57.6M | 0.53% | 46 |
|
|
2015
Q2 | $752M | Buy |
5,498,822
+97,848
| +2% | +$13.4M | 0.69% | 40 |
|
|
2015
Q1 | $673M | Sell |
5,400,974
-260,013
| -5% | -$32.4M | 0.62% | 49 |
|
|
2014
Q4 | $512M | Sell |
5,660,987
-304,901
| -5% | -$27.6M | 0.48% | 57 |
|
|
2014
Q3 | $430M | Buy |
5,965,888
+618,153
| +12% | +$44.6M | 0.4% | 60 |
|
|
2014
Q2 | $333M | Sell |
5,347,735
-2,672,017
| -33% | -$166M | 0.31% | 76 |
|
|
2014
Q1 | $547M | Sell |
8,019,752
-1,376,324
| -15% | -$93.9M | 0.52% | 56 |
|
|
2013
Q4 | $660M | Buy |
9,396,076
+519,719
| +6% | +$36.5M | 0.65% | 45 |
|
|
2013
Q3 | $641M | Buy |
8,876,357
+1,642,434
| +23% | +$119M | 0.67% | 42 |
|
|
2013
Q2 | $404M | Buy |
+7,233,923
| New | +$404M | 0.45% | 59 |
|